Rafferty Asset Management, LLC Nektar Therapeutics Transaction History

Rafferty Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$2.03 - $4.28 $39,946 - $84,221	-19,678 Reduced 58.53%	13,942 $31,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $114,839 - $194,168	-37,776 Reduced 52.91%	33,620 $108,000
Q2 2022 Aug 12, 2022	BUY	$3.17 - $6.17 $152,229 - $296,295	48,022 Added 205.45%	71,396 $271,000
Q1 2022 May 13, 2022	SELL	$4.16 - $13.72 $3,598 - $11,867	-865 Reduced 3.57%	23,374 $126,000
Q4 2021 Feb 10, 2022	BUY	$10.83 - $18.41 $83,098 - $141,259	7,673 Added 46.32%	24,239 $327,000

Q3 2021 Nov 10, 2021	BUY	$13.07 - $18.84 $72,734 - $104,844	5,565 Added 50.59%	16,566 $298,000
Q2 2021 Aug 10, 2021	BUY	$16.52 - $20.4 $181,736 - $224,420	11,001 New	11,001 $189,000
Q1 2021 May 10, 2021	SELL	$16.56 - $25.46 $276,535 - $425,156	-16,699 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$15.77 - $19.03 $263,343 - $317,781	16,699 New	16,699 $284,000
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $304,011 - $454,276	-18,325 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$16.86 - $23.44 $308,959 - $429,538	18,325 New	18,325 $424,000
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $277,100 - $535,434	-19,150 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$15.87 - $23.12 $99,679 - $145,216	-6,281 Reduced 24.7%	19,150 $413,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $430,038 - $922,382	25,431 New	25,431 $463,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.